302 related articles for article (PubMed ID: 32444551)
1. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.
Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X
J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551
[TBL] [Abstract][Full Text] [Related]
2.
Tsai RM; Bejanin A; Lesman-Segev O; LaJoie R; Visani A; Bourakova V; O'Neil JP; Janabi M; Baker S; Lee SE; Perry DC; Bajorek L; Karydas A; Spina S; Grinberg LT; Seeley WW; Ramos EM; Coppola G; Gorno-Tempini ML; Miller BL; Rosen HJ; Jagust W; Boxer AL; Rabinovici GD
Alzheimers Res Ther; 2019 Jan; 11(1):13. PubMed ID: 30704514
[TBL] [Abstract][Full Text] [Related]
3. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N
Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680
[TBL] [Abstract][Full Text] [Related]
4. Frontotemporal dementia with the V337M
Spina S; Schonhaut DR; Boeve BF; Seeley WW; Ossenkoppele R; O'Neil JP; Lazaris A; Rosen HJ; Boxer AL; Perry DC; Miller BL; Dickson DW; Parisi JE; Jagust WJ; Murray ME; Rabinovici GD
Neurology; 2017 Feb; 88(8):758-766. PubMed ID: 28130473
[TBL] [Abstract][Full Text] [Related]
5. [
Wolters EE; Papma JM; Verfaillie SCJ; Visser D; Weltings E; Groot C; van der Ende EL; Giannini LAA; Tuncel H; Timmers T; Boellaard R; Yaqub M; van Assema DME; Kuijper DA; Segbers M; Rozemuller AJM; Barkhof F; Windhorst AD; van der Flier WM; Pijnenburg YAL; Scheltens P; van Berckel BNM; van Swieten JC; Ossenkoppele R; Seelaar H
Neurology; 2021 Sep; 97(10):e1017-e1030. PubMed ID: 34210823
[TBL] [Abstract][Full Text] [Related]
6. 18F-MK-6240 tau-PET in genetic frontotemporal dementia.
Levy JP; Bezgin G; Savard M; Pascoal TA; Finger E; Laforce R; Sonnen JA; Soucy JP; Gauthier S; Rosa-Neto P; Ducharme S
Brain; 2022 Jun; 145(5):1763-1772. PubMed ID: 34664612
[TBL] [Abstract][Full Text] [Related]
7. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
[TBL] [Abstract][Full Text] [Related]
8. In vivo
Jones DT; Knopman DS; Graff-Radford J; Syrjanen JA; Senjem ML; Schwarz CG; Dheel C; Wszolek Z; Rademakers R; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Boeve BF
Neurology; 2018 Mar; 90(11):e947-e954. PubMed ID: 29440563
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.
Yousefzadeh-Nowshahr E; Winter G; Bohn P; Kneer K; von Arnim CAF; Otto M; Solbach C; Anderl-Straub S; Polivka D; Fissler P; Strobel J; Kletting P; Riepe MW; Higuchi M; Glatting G; Ludolph A; Beer AJ;
PLoS One; 2022; 17(4):e0266906. PubMed ID: 35404966
[TBL] [Abstract][Full Text] [Related]
10. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
[TBL] [Abstract][Full Text] [Related]
11. In Vivo
Zhou XY; Lu JY; Liu FT; Wu P; Zhao J; Ju ZZ; Tang YL; Shi QY; Lin HM; Wu JJ; Yen TC; Zuo CT; Sun YM; Wang J
Mov Disord; 2022 Mar; 37(3):525-534. PubMed ID: 34842301
[TBL] [Abstract][Full Text] [Related]
12. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.
Smith R; Puschmann A; Schöll M; Ohlsson T; van Swieten J; Honer M; Englund E; Hansson O
Brain; 2016 Sep; 139(Pt 9):2372-9. PubMed ID: 27357347
[TBL] [Abstract][Full Text] [Related]
13. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H
Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589
[TBL] [Abstract][Full Text] [Related]
15. Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriers.
Deters KD; Risacher SL; Farlow MR; Unverzagt FW; Kareken DA; Hutchins GD; Yoder KK; Murrell JR; Spina S; Epperson F; Gao S; Saykin AJ; Ghetti B
Am J Neurodegener Dis; 2014; 3(3):103-14. PubMed ID: 25628962
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal (
Convery RS; Jiao J; Clarke MTM; Moore KM; Koriath CAM; Woollacott IOC; Weston PSJ; Gunn R; Rabiner I; Cash DM; Rossor MN; Warren JD; Fox NC; Ourselin S; Bocchetta M; Rohrer JD
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):106-108. PubMed ID: 31439620
[No Abstract] [Full Text] [Related]
17. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
[TBL] [Abstract][Full Text] [Related]
18. Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study.
Schröter N; Blazhenets G; Frings L; Barkhausen C; Jost WH; Weiller C; Rijntjes M; Meyer PT
Clin Nucl Med; 2020 Apr; 45(4):283-287. PubMed ID: 32108694
[TBL] [Abstract][Full Text] [Related]
19. Reconfigured metabolism brain network in asymptomatic microtubule-associated protein tau mutation carriers: a graph theoretical analysis.
Liu L; Chu M; Nie B; Liu L; Xie K; Cui Y; Kong Y; Chen Z; Nan H; Chen K; Rosa-Neto P; Wu L
Alzheimers Res Ther; 2022 Apr; 14(1):52. PubMed ID: 35410286
[TBL] [Abstract][Full Text] [Related]
20. High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.
Tagai K; Ono M; Kubota M; Kitamura S; Takahata K; Seki C; Takado Y; Shinotoh H; Sano Y; Yamamoto Y; Matsuoka K; Takuwa H; Shimojo M; Takahashi M; Kawamura K; Kikuchi T; Okada M; Akiyama H; Suzuki H; Onaya M; Takeda T; Arai K; Arai N; Araki N; Saito Y; Trojanowski JQ; Lee VMY; Mishra SK; Yamaguchi Y; Kimura Y; Ichise M; Tomita Y; Zhang MR; Suhara T; Shigeta M; Sahara N; Higuchi M; Shimada H
Neuron; 2021 Jan; 109(1):42-58.e8. PubMed ID: 33125873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
